Gemini Therapeutics announced that David Lubner has been appointed to serve as an independent member of its Board of Directors. Mr. Lubner has served as Executive Vice President and Chief Financial Officer of Ra Pharma, which was acquired by UCB in April 2020. Before joining Ra Pharma, Mr. Lubner served as a member of the senior management teams of Tetraphase Pharmaceuticals, Inc., PharMetrics Inc., and ProScript.